Lexpos News

/Lexpos News/

Drug Tariff Watch – May 2024

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2024. Part XVI – Notes on charges Contractors should note: the increase in prescription charges from £9.65 to £9.90. pre-payment certificates have increased from £111.60 for [...]

The post Drug Tariff Watch – May 2024 appeared first on Community Pharmacy England.

By |April 26th, 2024|Lexpos News|Comments Off on Drug Tariff Watch – May 2024

Medicine Supply Notification: Mesalazine (Asacol® ) 400mg MR gastro-resistant tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Mesalazine (Asacol®) 400mg MR gastro-resistant tablets MSN/2024/048 Tier 2 – medium impact Date of issue 25th April 2024 Asacol® 400mg MR gastro-resistant tablets (pack size 168) was discontinued in March 2024; all stocks have now been exhausted. Asacol® 400mg MR gastro-resistant [...]

The post Medicine Supply Notification: Mesalazine (Asacol® ) 400mg MR gastro-resistant tablets appeared first on Community Pharmacy England.

By |April 26th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Mesalazine (Asacol® ) 400mg MR gastro-resistant tablets

Medicine Supply Notification: Daktacort® (hydrocortisone 1% / miconazole 2%) cream

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Daktacort® (hydrocortisone 1% / miconazole 2%) cream MSN/2024/047 Tier 2 – medium impact Date of issue: 25th April 2024 Daktacort® (hydrocortisone 1% / miconazole 2%) cream (30g, POM) has been discontinued with remaining supplies due to be exhausted by the end [...]

The post Medicine Supply Notification: Daktacort® (hydrocortisone 1% / miconazole 2%) cream appeared first on Community Pharmacy England.

By |April 26th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Daktacort® (hydrocortisone 1% / miconazole 2%) cream

Pharmacy stakeholder group produces Patient Safety Professional Standards

Community Pharmacy England and others have contributed to the Royal Pharmaceutical Society’s (RPS) revised professional standards for responding to patient safety incidents. The Patient Safety Professional Standards: Responding to Patient Safety Incidents has been developed by the RPS, Association of Pharmacy Technicians UK and Pharmacy Forum NI, with the support of a steering group and a [...]

The post Pharmacy stakeholder group produces Patient Safety Professional Standards appeared first on Community Pharmacy England.

By |April 24th, 2024|Lexpos News|Comments Off on Pharmacy stakeholder group produces Patient Safety Professional Standards

Medicine Supply Notification: Naloxegol (Moventig® ) 12.5mg and 25mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Naloxegol (Moventig® ) 12.5mg and 25mg tablets MSN/2024/045 Tier 2 – medium impact Date of issue: 23rd April 2024 Naloxegol (Moventig®) 12.5mg tablets are out of stock until early August 2024. Naloxegol (Moventig®) 25mg tablets are out of stock until the [...]

The post Medicine Supply Notification: Naloxegol (Moventig® ) 12.5mg and 25mg tablets appeared first on Community Pharmacy England.

By |April 23rd, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Naloxegol (Moventig® ) 12.5mg and 25mg tablets